• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

BiomeSense Nabs $2M to Expand Daily Gut Microbiome Tracking Platform

by Fred Pennic 10/04/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

BiomeSense Nabs $2M to Expand Biosensor & Analytics Platform for Daily Gut Microbiome Tracking

– BiomeSense raises $2M in seed funding to expand its biosensor and analytics platform for daily gut microbiome tracking.

– The company is working on completing its prototype biosensor and data modeling platform in preparation for the first clinical trials, scheduled for 2020.

– The trials will investigate cancer progression, immunotherapy response, surgical recovery and athletic performance.

BiomeSense, a Chicago, IL-based microbiome startup developing a novel biosensor and analytics platform for daily gut microbiome tracking has raised $2M in seed funding led by BioX Clan with participation from Seerave Foundation and SOSV.

Enabling Continuous Microbiome Testing

Founded in 2018 by Kevin Honaker and Dr. Jack Gilbert, BiomeSense is developing an at-home biosensor to produce continuous gut microbiome data and a cloud-based analytics platform to turn that data into actionable clinical insights. The company provides this solution to scientists studying the microbiome, delivering dramatically more data over the course of a trial than currently available and enabling an unprecedented understanding of how short-term changes in the microbiome influence clinical outcomes.

Expansion to Complete Prototype Biosensor and Data Modeling Platform

The company plans to use the seed funding to complete its prototype biosensor and data modeling platform in preparation for first clinical trials, scheduled for 2020. Those trials were oversubscribed within weeks of their availability, reflecting the widespread support BiomeSense has received from the research community since its launch from the Polsky Center at The University of Chicago.

Indicating the breadth of the impact a better understanding of the gut microbiome can have on human health, those trials will investigate cancer progression, immunotherapy response, surgical recovery and athletic performance.

Human Microbiome: The Next Frontier of Precision Medicine

“The human microbiome is the next frontier of precision medicine with enormous possibilities for improving our health,” said Kevin Honaker, BiomeSense co-founder and CEO. “Understanding how and why the microbiome changes over time is key to fully unlocking that potential, but today, getting continuous data at a reasonable cost is impossible.

“Now, thanks to the confidence of our funding and research partners, we’ll be able to launch the first-ever solution to that problem in human trials next year.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: BiomeSense, Gut Microbiome, microbiome

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Knowledge Hub

10 Critical KPIs Every Successful Healthcare Organization is Implementing10 Critical KPIs Every Successful Healthcare Organization is Implementing

How to Build Hybrid Care Models Around Remote Patient Monitoring

How to Build Hybrid Care Models Around Remote Patient Monitoring

Most Popular

Recent Digital Health Partnerships

Roundups: 15 Recent Digital Health Strategic Partnerships

Recent Digital Health Executive Hires & Board Appointments

Digital Health Executive Hires: Practice Better Appoints CEO, HHAeXchange, Intelerad, Tegria, Others

M&A: Florence Acquires Virtual Care Solution Zipnosis

M&A: Florence Acquires Virtual Care Solution Zipnosis

Adopting Value-Based Care Models for Autism Care Is Imperative

Why Adopting Value-Based Care Models for Autism Care Is Imperative

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

UNC Health to Pilot Epic, Microsoft’s Generative AI Tool

Vanderbilt University Medical Center Taps Philips Reduce Carbon Footprint

Vanderbilt University Medical Center Taps Philips to Reduce Carbon Footprint

Denials Management Named Most Time-Consuming Task in RCM

Denials Management Named Most Time-Consuming Task in RCM

How AI Can Eliminate Surprise Bills, Improve Payment Integrity

AI Can Eliminate Surprise Bills, Improve Payment Integrity

Q/A: IQVIA’s Global Lead Talks Unlocking AI for Drug Repurposing

M&A: Kaiser Acquires Geisinger, Forms Risant Health

5 Executives Weigh in on VBC Impact on Kaiser/Geisinger Deal

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |